Seite auswählen

 

The Innovation in Pain Therapy

Mission

SzeleSTIM is a Medical Device Startup in Vienna, Austria, which aims to disrupt the global electroceutical market. We provide sustainable therapies for patients with severe chronic and acute pain. Our product is a wearable electromedical device for Auricular Vagus Nerve Stimulation, allowing minimal-invasive and non-pharmacological therapy adapted to the individual patient.

 

Auricular Vagus Nerve Stimulation

Electrical stimulation of the Vagus Nerve in the ear (auricle) modulates the brainstem, boosts the regeneration capacity of the body, and fights chronic / acute pain. This allows for non-pharmacological pain treatment with a proven sustainable effect and a low side effect profile.

Innovative Pain Treatment

Our body-worn neuromodulation device is easy to apply and provides an individual adaptation of stimulation for optimal pain treatment. It is minimal-invasive and provides the patient with full mobility and improved quality of life.

R

Non-pharmacological

R

Sustainable

R

Life quality

Team

Jozsef Constantin Széles

Jozsef Constantin Széles

Innovator / Founder

Inventor and inspiring mind with decades of clinical expertise at MedUni Vienna.

Dorian Széles

Dorian Széles

Sales / Founder

Boosts our business with his expertise in the medical
device market.

Thomas Puchegger

Thomas Puchegger

Finance / Founder

Ensures the companies „checks and balances“ with his back-ground in finance.

Stefan Kampusch

Stefan Kampusch

Development / Founder

Keeps the company running and takes care of product development.

Eugenijus Kaniusas

Eugenijus Kaniusas

Research / Founder

Leads our research driven development with his
expertise at TU Wien.

Andreas Dittrich

Andreas Dittrich

Business Development

Brings our products to the right people by his experience and network.

We are in product development and certification.

Meanwhile please also visit our partner Multisana.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 807694.